case control study to compare level of interleukin 38 in patients with psoriasis and patients with metabolic syndrome with healthy control subjects
this case control study will measure plasma level of interleukin 38 in 4 groups of 24 subject, group one will have psoriatic patients, group 2 will have psoriatic patients with metabolic syndrome, group three will have patients with metabolic syndrome only, and group 4 will have healthy control subjects.
Study Type
OBSERVATIONAL
Enrollment
96
draw 5 ml of venous blood into EDTA tubes and centrifuged then plasma is separated for test
measure plasma level of interleukin 38 in all groups
level of interleukin 38 will be measured and compared in all groups to asses the relationship between this interleukin and metabolic syndrome in psoriatic patients
Time frame: through study completion an average of 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.